Trials / Completed
CompletedNCT04404374
Treatment of Periodontal Intrabony Defects With A-PRF+ or EMD
Efficacy of a New-generation Platelet-rich Fibrin vs. Enamel Matrix Derivatives in the Treatment of Periodontal Intrabony Defects : a Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Semmelweis University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized clinical trial was to clinically evaluate and compare the healing of intrabony defects after treatment with advanced platelet-rich fibrin (A-PRF+) to enamel matrix derivatives (EMD) in periodontitis patients.
Detailed description
Thirty (30) intrabony defects of 18 patients (9 males, 9 females) were randomly divided in two treatment groups: test (n = 15) and control (n = 15). The intrabony defects were filled with A-PRF+ (n=15) in the test group, respectively with EMD in the control group, and fixed with sutures to ensure wound closure and stability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | A-PRF/EMD | Comparing healing effect of an autologous and a xenogenic product |
Timeline
- Start date
- 2018-06-27
- Primary completion
- 2020-06-30
- Completion
- 2020-12-31
- First posted
- 2020-05-27
- Last updated
- 2021-03-05
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT04404374. Inclusion in this directory is not an endorsement.